Results 151 to 160 of about 63,563 (260)

Antibiotics in Veterinary Ophthalmology: Resistance, Stewardship, and Emerging Antibiotic‐Sparing Strategies

Veterinary Ophthalmology, Volume 29, Issue 4, July 2026.
ABSTRACT Antimicrobial resistance (AMR) is a growing challenge in veterinary ophthalmology, particularly in cases of bacterial keratitis, where progressive stromal infection can threaten vision and globe integrity within hours to days. This review synthesizes current evidence on pathogen distribution, antimicrobial susceptibility profiles, multidrug ...
Lionel Sebbag, Oren Pe'er
wiley   +1 more source

Larval Conjunctivitis [PDF]

BMJ, 1950
openaire   +2 more sources

Corneal Lesions Associated With Feline Herpesvirus-1 Modified Live Vaccine Strain F2 in Two Cats. [PDF]

Case Rep Vet Med
Suga Y, Maehara S, Saito A, Kitamura Y, Kirisawa R.   +4 more
europepmc   +1 more source

Borates in Biomedicine: A Retrospective Analysis

ChemMedChem, Volume 21, Issue 11, 15 June 2026.
The graphical abstract displays the molecular structure of boric acid, an hormetic substance with pleiotropic bioactivity. Complementing previous studies describing the use of organoboron compounds as potent therapeutics for use in anticancer, antimicrobial, antiparasitic, and related other pharmaceutical uses, this study focuses on the emerging ...
Mario Pagliaro, Giovanna Li Petri, Giuseppe Angellotti, Rosaria Ciriminna   +3 more
wiley   +1 more source

Developing consensus definitions and methods for non-visually impairing eye conditions for population-based eye surveys in Nigeria: a Delphi study. [PDF]

BMJ Open
Aghaji A, Okoye O, Nwachukwu NZ, Ezegwui I, Okoye O, Umeh R, Gilbert CE, Nigeria National Non-Visually Impairing Conditions Study Group.   +7 more
europepmc   +1 more source

Parinaud's Conjunctivitis [PDF]

Proceedings of the Royal Society of Medicine, 1928
openaire   +3 more sources

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

Advanced Science, Volume 13, Issue 35, 24 June 2026.
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun, Haochen Yang, Qing Xu, Xingya Li, Jinxing Lou, Jianchun Duan, Jiachen Xu, Zhuqing Liu, Yong Xia, Zhicai Lin, Linlin Li, Dan Sun, Jiaguo Li, Tao Liu, Jun Guo, Wenfeng Xu, Weimin Zhu, Yi Liu, Boyang Sun, Jia Zhong, Lijie Rong, Qijun Qian, Chenqi Xu, Jie Wang   +23 more
wiley   +1 more source

CSF-net: a color space fusion network with self-attention-driven feature learning for feline ocular diseases classification. [PDF]

Front Vet Sci
S P D, Lee M, Yang HJ.
europepmc   +1 more source

Allergic Contact Dermatitis From Dorzolamide Without Cross‐Reactivity to Brinzolamide

Contact Dermatitis, Volume 95, Issue 1, Page 116-117, July 2026.
Elias Ghozli, Camille Leleu, Louis Arnould, Louise Collin, Evelyne Collet   +4 more
wiley   +1 more source

Local Specific IgE Levels Can Predict and Monitor the Therapeutic Response to Subcutaneous Immunotherapy With House Dust Mite

International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 561-571, June 2026.
ABSTRACT Background Identifying predictive and monitoring biomarkers for allergen immunotherapy response is crucial for enhancing clinical efficacy. This study aims to investigate the systemic and local levels of immunoglobulins and identify potential biomarkers in house dust mite (HDM) allergic rhinitis (AR) patients who are undergoing subcutaneous ...
Xu Xu, Jingyun Li, Xu Zhang, Yu Song, Lin Xi, Luo Zhang, Yuan Zhang   +6 more
wiley   +1 more source